Jeroen van de Pol

177 6 General discussion Within these pilots, special attention should be given to alternate reimbursement models. Such models can have major implications for both healthcare insurance companies and community pharmacists. It is, therefore, essential that different stakeholders are provided with insights into how a different reimbursement model affects revenues. Without these insights, different stakeholders may be hesitant to support the implementation of a new reimbursement model (due to a fear of the unknown). Therefore, within the pilot setting, agreements should be made about participating community pharmacists’ revenues. These agreements will likely provide sufficient trust from both community pharmacists and healthcare insurance companies to encourage participation and should provide professional bodies and policymakers with the knowledge to assess the impact of an altered reimbursement model. Sustain acceleration After the first successful implementation and positive results of CPS services in pilot settings that underpin the added value of CPS, subsequent steps should be made toward the normalization of specific CPS provision [96]. These steps should first include implementing the specific CPS in other community pharmacies around the country to normalized it within the profession. This step also reduces the amount of practice variation within the profession and further enables professional bodies to strengthen CPS in daily practice by developing professional guidelines and creating quality indicators. This will create a situation in which CPS becomes increasingly normalized within the community pharmacy profession, instead of being considered add-on for dispensing. Responsibility in sustaining acceleration predominantly lies with the pharmacy profession and thus the Royal Dutch Pharmacists Association.